Author(s): Morais, João
Date: 2025
Persistent ID: http://hdl.handle.net/10400.8/14298
Origin: IC-online
Subject(s): diabetes; antithrombotic therapy
Author(s): Morais, João
Date: 2025
Persistent ID: http://hdl.handle.net/10400.8/14298
Origin: IC-online
Subject(s): diabetes; antithrombotic therapy
The study published by Baptista et al.1 sought to assess the quality of antithrombotic therapy in a group of 996 patients with diabetes prior to coronary percutaneous intervention, searching for how guidelines are being applied in a realworld setting.